BCAB – bioatla, inc. (US:NASDAQ)
Stock Stats
News
BioAtla, Inc. (NASDAQ: BCAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
BioAtla Reports First Quarter 2024 Financial Results and Highlights Recent Progress [Yahoo! Finance]
BioAtla Reports First Quarter 2024 Financial Results and Highlights Recent Progress
BioAtla to Participate in the Citizens JMP Life Sciences Conference
BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024
Form 10-Q BioAtla, Inc. For: Mar 31
Form 8-K BioAtla, Inc. For: May 14
Form 4 BioAtla, Inc. For: Apr 30 Filed by: Smith Scott Andrew
Form 4 BioAtla, Inc. For: Apr 30 Filed by: Sievers Eric
Form 8-K BioAtla, Inc. For: Apr 22
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.